Preprocedural imaging to guide transcoronary ethanol ablation for refractory septal ventricular tachycardia.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
03 2019
Historique:
received: 26 10 2018
revised: 29 11 2018
accepted: 07 12 2018
pubmed: 18 12 2018
medline: 6 5 2020
entrez: 18 12 2018
Statut: ppublish

Résumé

Radiofrequency ablation (RF) of ventricular tachycardia (VT) due to intramural foci has a high recurrence rate. Several techniques, such as bipolar ablation, irrigated needle ablation catheter, and retrograde coronary venous ethanol ablation have been suggested. Transarterial coronary ethanol ablation (TCEA) can also be effective. We present a case series of TCEA guided with preprocedural imaging to correlated coronary arteries and the intramural substrate. We present three consecutive patients with previous RF of septal VT (100% male; age, 72.6 ± 11.01 years; two patients with hypertrophic cardiomyopathy, one with mechanical aortic valve prosthesis) that underwent TCEA. Cardiac magnetic resonance was performed in two patients and cardiac CT in all patients. Correlation of septal arteries with intramural substrate was analyzed before the procedure so TCEA was attempted according to this analysis. After last TCEA (6.3 ± 2.08 months) the VT burden was reduced in all patients (sum of all implantable cardioverter-defibrillator therapies [antitachycardia pacing and shock] before and after TCEA, 15.8 ± 3.73 vs 0.97 ± 0.63 therapies/month; P = 0.02). No complications occurred during TCEA. TCEA completely guided with previous magnetic resonance imaging and computed tomography scan to select the coronary artery in relation to the substrate seems to be feasible as an alternative strategy in cases of intramural VT refractory to RF ablation.

Sections du résumé

BACKGROUND
Radiofrequency ablation (RF) of ventricular tachycardia (VT) due to intramural foci has a high recurrence rate. Several techniques, such as bipolar ablation, irrigated needle ablation catheter, and retrograde coronary venous ethanol ablation have been suggested. Transarterial coronary ethanol ablation (TCEA) can also be effective. We present a case series of TCEA guided with preprocedural imaging to correlated coronary arteries and the intramural substrate.
METHODS AND RESULTS
We present three consecutive patients with previous RF of septal VT (100% male; age, 72.6 ± 11.01 years; two patients with hypertrophic cardiomyopathy, one with mechanical aortic valve prosthesis) that underwent TCEA. Cardiac magnetic resonance was performed in two patients and cardiac CT in all patients. Correlation of septal arteries with intramural substrate was analyzed before the procedure so TCEA was attempted according to this analysis. After last TCEA (6.3 ± 2.08 months) the VT burden was reduced in all patients (sum of all implantable cardioverter-defibrillator therapies [antitachycardia pacing and shock] before and after TCEA, 15.8 ± 3.73 vs 0.97 ± 0.63 therapies/month; P = 0.02). No complications occurred during TCEA.
CONCLUSIONS
TCEA completely guided with previous magnetic resonance imaging and computed tomography scan to select the coronary artery in relation to the substrate seems to be feasible as an alternative strategy in cases of intramural VT refractory to RF ablation.

Identifiants

pubmed: 30556327
doi: 10.1111/jce.13816
doi:

Substances chimiques

Ethanol 3K9958V90M

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

448-456

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Ivo Roca-Luque (I)

Arrhythmia Unit, Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Nuria Rivas-Gándara (N)

Arrhythmia Unit, Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Jaume Francisco-Pascual (J)

Arrhythmia Unit, Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Jose Rodriguez-Sanchez (J)

Cardiovascular Image Unit, Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Hug Cuellar-Calabria (H)

Cardiovascular Image Unit, Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Jose Rodriguez-Palomares (J)

Cardiovascular Image Unit, Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Bruno García-Del Blanco (B)

Interventional Cardiology Unit, Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Jordi Pérez-Rodon (J)

Arrhythmia Unit, Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Alba Santos-Ortega (A)

Arrhythmia Unit, Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Ferran Rosés-Noguer (F)

Arrhythmia Unit, Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Roger Marsal (R)

Engineering Unit, Abbott Medical, St. Paul, Minnesota.

Barbara Rubio (B)

Engineering Unit, Abbott Medical, St. Paul, Minnesota.

David García-Dorado García (DG)

Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Angel Moya Mitjans (A)

Arrhythmia Unit, Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH